1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 7:Results for ordinal logistic regression for change of visual acuity under treatment: subpopulation of subtotal occlusions
Effect Classes/Range Wald’s χ2 P Treatment Conservative, 5.70 b 83 (63.8%) b 0.0169 LIF, 47 (36.15%) (36.15%) Gender Male 93 0.01 b (71.5%) 0.9061 e Female, 37 (28.5%) (28.5%) Age 18–89 years 8.85 0.0029 Latency 1–312 hr 3.60 e 0.0579 e Initial visual acuity 1–3 4.28 0.0385
Note.—LIF indicates local intra-arterial fibrinolysis; b, baseline (reference) class; e, removed by backward elimination.